| 腫瘍・血液内科学 | |||||||
| Medical Oncology and Hematology | |||||||
| 整理番号 | 論文の種類 | 著者名 | 論文タイトル | 誌名・書名等 | 巻号ページ | 年 | doi |
| 2162001 | 原著 | Inoue Y, Okinaka K, Fuji S, Inamoto Y, Uchida N, Toya T, Ikegame K, Eto T, Ozawa Y, Iwato K, Kanda Y, Atsuta Y, Ogata M, Fukuda T | Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study. | Bone Marrow Transplant | Sep;56(9):2125-2136 | 2021 | 10.1038/s41409-021-01291-0 |
| 2162002 | 原著 | Wang Z, Kimura S, Iwasaki H, Takase K, Oshiro Y, Gamachi A, Makihara K, Ogata M, Daa T, Momosaki S, Takamatsu Y, Takeshita M. |
Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults. | Diagn Pathol | Jun 4;16(1):48 | 2021 | 10.1186/s13000-021-01107-1 |
| 2162003 | 原著 | Ito A, Nakano N, Tanaka T, Fuji S, Makiyama J, Inoue Y, Choi I,
Nakamae H, Nagafuji K, Takase K, Machida S, Takahashi T, Sawayama Y, Kamimura T, Kato K, Kawakita T, Ogata M, Sakai R, Shiratori S, Uchimaru K, Inamoto Y, Utsunomiya A, Fukuda T |
Improved survival of patients with aggressive ATL by increased use of allo-HCT: A prospective observational study. | Blood Adv | Oct 26;5(20):4156-4166 | 2021 | 10.1182/bloodadvances.2021004932 |
| 2162004 | 原著 | Sumimoto T, Nakahara R, Suzuki Y, Tanaka R, Yoshida N, Ogata M,
Itoh H |
Development of a Sensitive and High-throughput Assay for Simultaneous Quantification of Five Tyrosine Kinase Inhibitors and Two Active Metabolites in Human Plasma Using Ultra-performance Liquid Chromatography Coupled to Tandem Mass Spectrometry. | Ther Drug Monit | Online ahead of print | 2021 | 10.1097/FTD.0000000000000922 |
| 2162005 | 原著 | 松浦朋子、黒澤彩子、山口拓洋、森 文子、森 毅彦、田中正嗣、近藤忠一、坂本周子、藤井伸治、一戸辰夫、奈良美保、 前田智也、藤澤 信、名和由一郎、 中邑幸伸、南口仁志、大西 康、 高野久仁子、高橋 都、福田隆浩 |
同種移植後患者の就労に関する実態調査 -慢性GVHD等の自覚症状による仕事・生活への影響に関する検討。 | 日本造血・免疫細胞療法学会雑誌 | 10(4), 172-182 | 2021 | |
| 2162006 | 症例報告 | Nakahara R, Sumimoto T, Tanaka R, Ogata M, Itoh H. | Successful determination of imatinib re-administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction. | Clin Case Rep | Aug 16;9(8):e04357 | 2021 | 10.1002/ccr3.4357 |
| 2162007 | 症例報告 | 長松顕太郎、 高野久仁子、 坂田真規、 柳井優花、 片山映樹、 本田周平、 吉田奈津美、 河野利恵、 今村朋之、 緒方正男 |
Cidofovirが奏功した同種造血幹細胞移植後の血球貪食症候群と髄膜炎を伴った播種性アデノウイルス感染症. | 臨床血液 | 62: 251-256 | 2021 | 10.11406/rinketsu.62.251 |
| 2162008 | 原著 | Saburi M, Ogata M, Soga Y, Satou T, Itani K, Kohno K, Nakayama T | Association between platelet-associated immunoglobulin G levels and response to corticosteroid therapy in patients with newly diagnosed immune thrombocytopenia. | Acta Haematol | 144(5):528-533 | 2021 | 10.1159/000511698 |
| 2162009 | 原著 | Ogata M, Kawano R, Satou T, Takata H, Yoshida N, Honda S, Nagamatsu K, Takano K, Kohno K, Kirihara T, Sato K, Hiroshima Y, Sumi M, Kurihara T, Takeda W, Ueki T, Kobayashi H |
Kinetics and clinical significance of human herpesvirus 6 DNA shedding in saliva after allogeneic hematopoietic stem cell transplantation. | Transpl Infect Dis | Jun;23(3): e13512 | 2021 | 10.1111/tid.13512 |
| 2162010 | 原著 | Hara H, Mizusawa J, Hironaka S, Kato K, Daiko H, Abe T, Nakamura K, Ando N, Kitagawa Y |
Influence of preoperative chemotherapy-induced leukopenia on survival in patients with esophageal squamous cell carcinoma: exploratory analysis of JCOG9907. | Esophagus | Jan;18(1):41-48 | 2021 | 10.1007/s10388-020-00752-7 |
| 2162011 | 原著 | Yamaguchi K, Shimada Y, Hironaka S, Sugimoto N, Komatsu Y,
Nishina T, Omuro Y, Tamura T, Piao Y, Homma G, Jen MH, Liepa AM, Muro K |
Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial. | Clin Drug Investig | Jan;41(1):53-64 | 2021 | 10.1007/s40261-020-00979-3 |
| 2162012 | 原著 | Nakajima TE, Kadowaki S, Minashi K, Nishina T, Yamanaka T, Hayashi Y, Izawa N, Muro K, Hironaka S, Kajiwara T, Kawakami Y | Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric Cancer. | Clin Cancer Res | Feb 15;27(4):1029-1036 | 2021 | 10.1158/1078-0432.CCR-20-3559 |
| 2162013 | 原著 | Kawakami H, Hironaka S, Esaki T, Chayama K, Tsuda M, Sugimoto N,
Kadowaki S, Makiyama A, Machida N, Hirano H, Hirata K, Hara H, Yabusaki H, Komatsu Y, Muro K |
An Investigator-Initiated Phase 2 Study of Nivolumab Plus Low-Dose Ipilimumab as First-Line Therapy for Microsatellite Instability-High Advanced Gastric or Esophagogastric Junction Cancer (NO LIMIT, WJOG13320G/CA209-7W7). | Cancers (Basel) | Feb 15;13(4):805 | 2021 | 10.3390/cancers13040805 |
| 2162014 | 原著 | Tanzawa S, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira
K, Misumi T, Shiraishi K, Matsutani N, Tanaka H, Inaba M, Haruyama T,
Nakamura J, Kishikawa T, Nakashima M, Iwasa K, Fujiwara K, Kohyama T, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Ishida H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Fujimoto N, Yokoyama T, Gemba K, Tsuda T, Nakagawa H, Ono H, Shimizu T, Nakamura M, Kusumoto S, Hayashi R, Shirasaki H, Ochi N, Aoe K, Kanaji N, Kashiwabara K, Inoue H, Seki N |
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan. (SAMURAI study) | Ther Adv Med Oncol | Feb 27;13:1758835921998588. | 2021 | 10.1177/1758835921998588 |
| 2162015 | 原著 | Fujitani K, Shitara K, Takashima A, Koeda K, Hara H, Nakayama N, Hironaka S, Nishikawa K, Kimura Y, Amagai K, Hosaka H, Komatsu Y, Shimada K, Kawabata R, Ohdan H, Kodera Y, Nakamura M, Nakajima TE, Miyata Y, Moriwaki T, Kusumoto T, Nishikawa K, Ogata K, Shimura M, Morita S, Koizumi W | Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial. | Gastric Cancer | Mar;24(2):467-476 | 2021 | 10.1007/s10120-020-01131-y |
| 2162016 | 原著 | Yamaguchi K, Fuse N, Komatsu Y, Fujii H, Hironaka S, Omuro Y, Muro K, Yasui H, Ueda S, Nishina T, Watanabe M, Ohtsu A. | Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer. | Jpn J Clin Oncol | May 28;51(6):879-885 | 2021 | 10.1093/jjco/hyaa276 |
| 2162017 | 原著 | Otsuka T, Shirakawa T, Shimokawa M, Koga F, Kawaguchi Y, Ueda Y, Nakazawa J, Komori A, Otsu S, Arima S, Fukahori M, Okabe Y, Makiyama A, Taguchi H, Honda T, Shibuki T, Nio K, Ide Y, Mizuta T, Mitsugi K, Ureshino N. |
A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study. | Int J Clin Oncol | May;26(5):941-950 | 2021 | 10.1007/s10147-021-01859-2 |
| 2162018 | 原著 | Miura Y, Ando M, Yamazaki K, Hironaka S, Boku N, Muro K, Hyodo I. |
Time-dependent discrepancies between physician-assessed and patient-reported oxaliplatin-induced peripheral neuropathy in patients with metastatic colorectal cancer who received mFOLFOX6 plus bevacizumab: a post hoc analysis (WJOG4407GSS2). | Support Care Cancer | Jul;29(7):3715-3723 | 2021 | 10.1007/s00520-020-05891-2 |
| 2162019 | 原著 | Taguchi H, Otsuka T, Shimokawa M, Arima S, Hashimoto S, Ido A,
Koga F, Ueda Y, Nakazawa J, Komori A, Otsu S, Fukahori M, Makiyama A, Honda T, Shibuki T, Mizuta T, Mitsugi K, Nio K, Ide Y, Ureshino N, Shirakawa T. |
Gemcitabine Plus Nanoparticle Albumin-bound Paclitaxel Versus FOLFIRINOX for Recurrent Pancreatic Cancer After Resection. | Anticancer Res | Jul;41(7):3573-3582 | 2021 | 10.21873/anticanres.15145 |
| 2162020 | 原著 | Arima S, Kawahira M, Shimokawa M, Ido A, Koga F, Ueda Y, Nakazawa J, Komori A, Otsu S, Fukahori M, Makiyama A, Taguchi H, Honda T, Shibuki T, Mitsugi K, Nio K, Ide Y, Ureshino N, Mizuta T, Shirakawa T, Otsuka T. | Gemcitabine Plus Nab-Paclitaxel Versus FOLFIRINOX in Locally Advanced, Unresectable Pancreatic Cancer: A Multicenter Observational Study (NAPOLEON Study). | Pancreas | Aug 1;50(7):957-964 | 2021 | 10.1097/MPA.0000000000001859 |
| 2162021 | 原著 | Satoh T, Kato K, Ura T, Hamamoto Y, Kojima T, Tsushima T, Hironaka S, Hara H, Iwasa S, Muro K, Yasui H, Minashi K, Yamaguchi K, Ohtsu A, Doki Y, Matsumura Y, Kitagawa Y. | Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07). | Esophagus | Oct;18(4):835-843 | 2021 | 10.1007/s10388-021-00850-0 |